This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, M.-N.
Right arrow Articles by Pai, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, M.-N.
Right arrow Articles by Pai, C. H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2002, p. 1376-1380, Vol. 40, No. 4
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.4.1376-1380.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Clonal Spread of Staphylococcus aureus Heterogeneously Resistant to Vancomycin in a University Hospital in Korea

Mi-Na Kim,* Sang Hyun Hwang, Yeon-Jung Pyo, Hyang-Mi Mun, and Chik Hyun Pai

Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea

Received 2 October 2001/ Returned for modification 23 November 2001/ Accepted 10 January 2002

Since vancomycin-intermediate Staphylococcus aureus (VISA) was first reported in Japan in 1997, there has been great concern that heterogeneous vancomycin-intermediate S. aureus (hetero-VISA) is the putative precursor of VISA. To investigate the prevalence, clinical significance, and molecular epidemiology of S. aureus with reduced susceptibility to vancomycin, all consecutive isolates of S. aureus isolated from clinical specimens from December 1998 to August 1999 at Asan Medical Center were screened for VISA and hetero-VISA by using brain heart infusion agar containing 4 µg of vancomycin/ml. Screen-positive isolates were confirmed by susceptibility testing and population analysis of subpopulations with reduced susceptibility to vancomycin. The isolates confirmed as hetero-VISA were typed by pulsed-field gel electrophoresis (PFGE). Medical records were reviewed to evaluate the clinical significance and risk factors for the acquisition of hetero-VISA. Of the 4,483 isolates that were tested, 53 were screen positive; no VISA was detected, but 24 isolates (0.54%) from 22 patients were hetero-VISA. All but two strains appeared to be clones of the Korean VISA strain, AMC11094, in the PFGE analysis. A total of 18 patients were in intensive care units, and 16 underwent major surgeries during the same admission. Only 10 of the 22 patients had previous methicillin-resistant S. aureus infections and 11 had previous vancomycin or teicoplanin therapy. Only 7 of the 22 patients from whom hetero-VISA strains were isolated were infected, and the remaining 15 patients were colonized. All seven infected patients were successfully treated with vancomycin. These results suggest that hetero-VISA can be treated with vancomycin, but the spread of hetero-VISA clonal to VISA is of concern, since many believe that VISA can arise from hetero-VISA, although this phenomenon was not observed in this study.

* Corresponding author. Mailing address: Department of Clinical Pathology, Asan Medical Center, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Korea. Phone: 82-2-3010-4511. Fax: 82-2-478-0884. E-mail: mnkim{at}amc.seoul.kr.

Journal of Clinical Microbiology, April 2002, p. 1376-1380, Vol. 40, No. 4
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.4.1376-1380.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Musta, A. C., Riederer, K., Shemes, S., Chase, P., Jose, J., Johnson, L. B., Khatib, R. (2009). Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years. J. Clin. Microbiol. 47: 1640-1644 [Abstract] [Full Text]  
  • Chung, H.-J., Jeon, H.-S., Sung, H., Kim, M.-N., Hong, S.-J. (2008). Epidemiological Characteristics of Methicillin-Resistant Staphylococcus aureus Isolates from Children with Eczematous Atopic Dermatitis Lesions. J. Clin. Microbiol. 46: 991-995 [Abstract] [Full Text]  
  • Garnier, F., Chainier, D., Walsh, T., Karlsson, A., Bolmstrom, A., Grelaud, C., Mounier, M., Denis, F., Ploy, M.-C. (2006). A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital. J Antimicrob Chemother 57: 146-149 [Abstract] [Full Text]  
  • Sancak, B., Ercis, S., Menemenlioglu, D., Colakoglu, S., Hascelik, G. (2005). Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital. J Antimicrob Chemother 56: 519-523 [Abstract] [Full Text]  
  • Weese, J. S. (2005). Methicillin-Resistant Staphylococcus aureus: An Emerging Pathogen in Small Animals. Journal of the American Animal Hospital Association 41: 150-157 [Abstract] [Full Text]  
  • Song, J.-H., Hiramatsu, K., Suh, J. Y., Ko, K. S., Ito, T., Kapi, M., Kiem, S., Kim, Y.-S., Oh, W. S., Peck, K. R., Lee, N. Y., and the Asian Network for Surveillance of Resistan, (2004). Emergence in Asian Countries of Staphylococcus aureus with Reduced Susceptibility to Vancomycin. Antimicrob. Agents Chemother. 48: 4926-4928 [Abstract] [Full Text]  
  • Huang, V., Brown, W. J., Rybak, M. J. (2004). In Vitro Activities of a Novel Cephalosporin, CB-181963 (CAB-175), against Methicillin-Susceptible or -Resistant Staphylococcus aureus and Glycopeptide-Intermediate Susceptible Staphylococci. Antimicrob. Agents Chemother. 48: 2719-2723 [Abstract] [Full Text]  
  • Verdier, I., Reverdy, M.-E., Etienne, J., Lina, G., Bes, M., Vandenesch, F. (2004). Staphylococcus aureus Isolates with Reduced Susceptibility to Glycopeptides Belong to Accessory Gene Regulator Group I or II. Antimicrob. Agents Chemother. 48: 1024-1027 [Abstract] [Full Text]  
  • Bert, F., Clarissou, J., Durand, F., Delefosse, D., Chauvet, C., Lefebvre, P., Lambert, N., Branger, C. (2003). Prevalence, Molecular Epidemiology, and Clinical Significance of Heterogeneous Glycopeptide-Intermediate Staphylococcus aureus in Liver Transplant Recipients. J. Clin. Microbiol. 41: 5147-5152 [Abstract] [Full Text]  
  • Gustafson, J. E., O'Brien, F. G., Coombs, G. W., Malkowski, M. J., Grubb, W. B., Pfeltz, R. F., Wilkinson, B. J. (2003). Alterations in phage-typing patterns in vancomycin-intermediate Staphylococcus aureus. J Med Microbiol 52: 711-714 [Abstract] [Full Text]  
  • Kim, H. B., Park, W. B., Lee, K. D., Choi, Y. J., Park, S. W., Oh, M.-d., Kim, E.-C., Choe, K. W. (2003). Nationwide Surveillance for Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Korea. J. Clin. Microbiol. 41: 2279-2281 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»